Skip to main content

Articles By Bella Mehta, MBBS, MS

covid coronavirus virus

More severe COVID-19 outcomes in African American, Hispanic individuals with SLE

By Bella Mehta, MBBS, MS
15 November 2021

A study from ACR21 convergence discussing data from the Global Rheumatology Alliance (GRA) describes the association between race/ethnicity on COVID-19 outcomes specifically in lupus patients.

Read Article
Telemedicine

Telemedicine Enriched Care Model for Autoinflammatory Diseases

By Bella Mehta, MBBS, MS
09 November 2021

Traditionally telemedicine is thought to be a technology where a patient directly talks to a provider or a specialist; however, another concept of having a patient with a local primary care who in turn accesses specialists via video conferencing, is gaining some momentum.  

Read Article
Thermometer

JAK Inhibitors in Refractory Adult and Childhood-Onset Still’s Disease

By Bella Mehta, MBBS, MS
07 November 2021

Still's disease is an autoinflammatory disease characterized by spiking fever, rash, polyarthralgia, sore throat and even life-threatening complications, such as macrophage activation syndrome. It was first described by George Still in the late 1800s.

Read Article
chalkboard disparities black white

Racial disparities in Bilateral Knee Arthroplasty in Osteoarthritis

By Bella Mehta, MBBS, MS
01 December 2020

Although arthritis-related activity, disabling work limitations, and severe pain (which are indications for TKA) disproportionately impact African American patients compared to White patients, there are marked racial disparities documented in utilization and complications in unilateral total knee arthroplasty.  

Read Article
gout.MTP_.jpg

Decreasing immunogenicity, improving efficacy of pegloticase in gout

By Bella Mehta, MBBS, MS
07 November 2020

At #ACR20 three different medications are reviewed in different studies to decrease the immunogenicity of pegloticase – Methotrexate, Azathioprine and Mycophenolate Mofetil.  

Read Article
×